Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions

Virág Székely1, Izabel Patik2, Orsolya Ungvári2

  • 1Membrane protein research group, Institute of Enzymology, Research Centre for Natural Sciences, H-1117 Budapest, Hungary; Doctoral School of Molecular Medicine, Semmelweis University, H-1085 Budapest, Hungary.

Insights

Researchers identified fluorescent probes to simultaneously monitor drug uptake and efflux transporters in liver cells. These probes, including pyranine, Cascade Blue hydrazide, and sulforhodamine 101, aid in understanding drug interactions and liver detoxification processes.

Area of Science:

  • Hepatology and Pharmacology
  • Molecular Biology and Biochemistry

Background:

  • Hepatocyte detoxification relies on membrane transporters like ATP Binding Cassette (ABC) and Solute Carrier (SLC) proteins.
  • Organic anion-transporting polypeptide 1B1 (OATP1B1) mediates drug uptake, while ABC transporters (e.g., MRP2, ABCG2) handle efflux into bile.
  • Monitoring drug interactions with these transporters is crucial for pharmacological relevance.

Purpose of the Study:

  • To identify fluorescent probes for simultaneous characterization of hepatic uptake (OATP) and efflux (ABC) transporter functions.
  • To assess the interaction of novel fluorescent OATP substrates with MRP2 and ABCG2 transporters.

Main Methods:

  • Transport assays using inside-out membrane vesicles (IOVs) to screen efflux transporter activity.
  • Transcellular transport studies in MDCKII cells co-expressing OATP1B1 with MRP2 or ABCG2.
  • Evaluation of fluorescent dyes including pyranine, Cascade Blue hydrazide (CB), and sulforhodamine 101 (SR101).

Main Results:

  • Pyranine was identified as a general substrate for OATP1B1, OATP1B3, and OATP2B1.
  • Live/Dead Violet and CB demonstrated utility for investigating ABCG2 function in IOVs.
  • Pyranine, CB, and SR101 serve as the first dual probes for simultaneously measuring OATP1B1 and MRP2 function in polarized cells.

Conclusions:

  • Novel fluorescent probes enable simultaneous assessment of hepatic drug uptake and efflux transporter activity.
  • These probes facilitate a deeper understanding of drug interactions and liver detoxification mechanisms.
  • The developed fluorescent methods offer a valuable tool for pharmacological research and drug development.